Effectiveness of a Treatment With the Robot - Assisted Gait Training System Walkbot in Patients With Cerebral Palsy
1 other identifier
interventional
23
1 country
1
Brief Summary
The improvement of walking capacity is a key objective of the rehabilitation of children with PC. There are different approaches from physiotherapy to address this need, including walking on the ground and on treadmill with partial weight support. Currently, there are robotic technologies adapted to the functional rehabilitation of patients. Assisted gait training with robotic devices such as the Walkbot allows a longer duration of training, at more variable speeds, and with a constant gait pattern adapted to the patient. This training, based on the intensity and repetition of the movement, has beneficial effects on the recovery and improvement of the patient's postural and locomotor functions. There are some studies that evaluate walking interventions on treadmill with partial weight support, on the ground and in assisted walking robot in patients with PC. Currently, there are no studies conducted that report the effectiveness of interventions performed with robotic walking training device Walkbot K on PC. However, studies in adults with Walkbot S, affected with neurological injury, have reported good results. Assisted gait training with robotic devices such as the Walkbot, based on the intensity and repetition of the movement, has beneficial effects on the recovery and improvement of the patient's postural and locomotor functions. However, due to the little evidence that exists, it is necessary to know the effectiveness of the Walkbot assisted walking robot in these patients by means of a clinical trial that allows to firmly establish the scope of its benefits.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 8, 2019
CompletedFirst Submitted
Initial submission to the registry
March 7, 2020
CompletedFirst Posted
Study publicly available on registry
April 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 14, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 14, 2021
CompletedMay 4, 2021
May 1, 2021
1.9 years
March 7, 2020
May 2, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Ability and quality of walking.
Changes in Gross Motor Function Measure-88 (dimensions IV y V)
Baseline, immediately after the intervention, 1 month after the intervention, 3 months after the intervention
Secondary Outcomes (6)
Functionality and autonomy
Baseline, immediately after the intervention, 1 month after the intervention, 3 months after the intervention
Muscle strength
Baseline, immediately after the intervention, 1 month after the intervention, 3 months after the intervention
Range of motion
Baseline, immediately after the intervention, 1 month after the intervention, 3 months after the intervention
Spasticity
Baseline, immediately after the intervention, 1 month after the intervention, 3 months after the intervention
Quality of walking: Edinburgh Visual Gait Scale
Baseline, immediately after the intervention, 1 month after the intervention, 3 months after the intervention
- +1 more secondary outcomes
Study Arms (2)
Intervention arm
EXPERIMENTALAssisted gait training with Walkbot System and their usual Physical Therapy.
Control arm
ACTIVE COMPARATORTheir usual Physical Therapy.
Interventions
The experimental group will receive at least 3 treatment sessions per week consisting of 40 minutes in robot-assisted gait training with Walkbot System in addition to their usual Physical therapy sessions. In total, the number of Walkbot sessions will be 20, in uninterrupted weeks.
The control group will receive their usual Physical therapy sessions during 6 weeks.
Eligibility Criteria
You may qualify if:
- Cerebral palsy diagnosis (diplegia or tetraplegia)
- Ability to communicate even if not verbal (yes/not; gestures; pictograms; sounds)
- Levels II, III and IV in GMFCS
- Unsupported seating capacity
- Go on standing with or without help
- Not receiving therapy with a walking robot and not having received it in at least one year
You may not qualify if:
- Serious psychiatric problems
- Serious heart problems
- Active tumors
- Severe joint degenerative problems
- Degenerative diseases of the nervous system
- Mitochondrial diseases
- Recent surgeries
- Unbound fractures
- Severe osteoporosis
- Uncontrolled seizures
- Open wounds in the lower half of the body
- Extreme fear of being placed in robotic devices
- Anthropomorphic measures are below the minimum required to use the device
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Raquel Olmos Gómez
Yecla, Murcia, 30510, Spain
Related Publications (1)
Olmos-Gomez R, Calvo-Munoz I, Gomez-Conesa A. Treatment with robot-assisted gait trainer Walkbot along with physiotherapy vs. isolated physiotherapy in children and adolescents with cerebral palsy. Experimental study. BMC Neurol. 2024 Jul 15;24(1):245. doi: 10.1186/s12883-024-03750-9.
PMID: 39009990DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
March 7, 2020
First Posted
April 1, 2020
Study Start
April 8, 2019
Primary Completion
March 14, 2021
Study Completion
March 14, 2021
Last Updated
May 4, 2021
Record last verified: 2021-05